Erudio Healtherudio.com
Sponsor
ImmunityBio trials: what clinicians said in public
An HCP commentary report on 1 clinical trial sponsored by ImmunityBio: QUILT-3.055. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 7 more trials with public commentary and no report yet.
Listed by lead sponsor as registered on ClinicalTrials.gov (ImmunityBio, Inc.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| QUILT-3.055 NCT03228667 · ImmunityBio, Inc. | cancer previously treated with immune checkpoint inhibitors | Phase 2 | 91 | 13 | Focused | Nov 20, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| QUILT-3.032 NCT03022825 · ImmunityBio, Inc. DeepView → | BCG-unresponsive high-grade non-muscle invasive bladder cancer | Phase 2/Phase 3 | Deep | View | |||
| QUILT-88 NCT04390399 · ImmunityBio, Inc. FocusedView → | Not given | Phase 2 | Focused | View | |||
| QUILT-3.078 NCT06061809 · ImmunityBio, Inc. FocusedView → | recurrent or progressive glioblastoma | Phase 2 | Focused | View | |||
| ResQ201A NCT06745908 · ImmunityBio, Inc. FocusedView → | immune checkpoint inhibitor-resistant stage IV NSCLC | Phase 3 | Focused | View | |||
| ResQ-209 NCT06710288 · ImmunityBio, Inc. FocusedView → | recurrent platinum-resistant high-grade ovarian cancer | Phase 2 | Focused | View | |||
| QUILT-3.076 NCT04898543 · ImmunityBio, Inc. FocusedView → | locally advanced or metastatic solid tumors | Phase 1 | Focused | View | |||
| QUILT-3.092 NCT05618925 · ImmunityBio, Inc. FocusedView → | relapsed/refractory non-Hodgkin lymphoma | Phase 1 | Focused | View | |||